Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-30
1993-10-12
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, A61K 3147
Patent
active
052525830
ABSTRACT:
The use of isoquinoline derivatives for the treatment of glaucoma or ocular hypertension. The isoquinoline derivatives are of formula I ##STR1## wherein R.sub.1 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl group and R.sub.2 is a C.sub.1 -C.sub.6 alkyl group. The stability of the isoquinoline derivatives when used in the form of a solution is improved by incorporating therein compounds having a phenolic hydroxyl group and/or glycols serving as a stabilizer.
REFERENCES:
patent: 4517365 (1985-05-01), Koyama et al.
patent: 4659833 (1987-04-01), Takahashi et al.
Physician's Desk Reference for Ophthamology, 16 Edition, 1988, p. 11.
Hatakeyama Shigeki
Kawase Shigeo
Sato Kiyoshi
Tadokoro Toyohiro
Ueno Masao
Fay Zohreh A.
Nisshin Flour Milling Co. Ltd.
LandOfFree
Isoquinoline derivatives for the treatment of glaucoma or ocular does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline derivatives for the treatment of glaucoma or ocular, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives for the treatment of glaucoma or ocular will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1904725